TITLE

Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers

AUTHOR(S)
Aurich, Ines; Mueller, Lutz P.; Aurich, Hendryk; Luetzkendorf, Jana; Tisljar, Kai; Dollinger, Matthias M.; Schormann, Wiebke; Waildorl, Jens; Hengstler, Jan G.; Fleig, Wolfgang E.; Christ, Bruno
PUB. DATE
March 2007
SOURCE
Gut;Mar2007, Vol. 56 Issue 3, p405
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Aims: At present, clinical success of hepatocyte transplantation as an alternative to whole liver transplantation is hampered by the limited availability of suitable donor organs for the isolation of transplantable hepatocytes. Hence, novel cell sources are required to deliver hepatocytes of adequate quality for clinical use. Mesenchymal stem cells (MSCs) from human bone marrow may have the potential to differentiate into hepatocytes in vitro and in vivo. Methods: Isolated MSCs were selected by density gradient centrifugation and plastic adherence, differentiated in the presence of human hepatocyte growth medium and transplanted in immunodeficient Pfp/Rag2 mice. Results: Here, we demonstrate that human MSCs gain in vitro the characteristic morphology and function of hepatocytes in response to specified growth factors. Specifically, preconditioned MSCs store glycogen, synthesise urea and feature the active hepatocyte-specific gene promoter of phosphoenolpyruvate carboxykinase (PCK1). After transplantation into livers of immunodeficient mice, preconditioned MSCs engraft predominantly in the periportal portion of the liver lobule. In situ, the cells continue to store glycogen and express PCK1, connexin32, albumin and the human hepatocyte-specific antigen HepParl, indicating that the transplanted cells retain prominent qualities of hepatocytes after their regional integration. Conclusion: MSCs derived from human bone marrow may serve as a novel source for the propagation of hepatocyte-like cells suitable for cell therapy in liver diseases.
ACCESSION #
24528573

 

Related Articles

  • Nonmyeloablative stem cell transplantation in metastatic renal cell carcinoma: delayed graft-versus-tumor effect is associated with chimerism conversion but transplantation has high toxicity. Massenkeil, G.; Roigas, J.; Nagy, M.; Wille, A.; Stroszczynski, C.; Mapara, M. Y.; Loening, S.; Dörken, B.; Arnold, R. // Bone Marrow Transplantation;Aug2004, Vol. 34 Issue 4, p309 

    Summary:Seven out of 29 patients with metastatic renal cell carcinoma (RCC) considered eligible for allogeneic stem cell transplantation underwent nonmyeloablative stem cell transplantation (NST) from HLA-identical donors. Conditioning comprised cyclophosphamide, fludarabine and antithymocyte...

  • Bone marrow and stem cell transplantation: Malaysian experience. Gan, G. G.; Teh, A.; Chan, L. L.; Cheong, S. K.; Chang, K. M.; Ibrahim, H. M. // Bone Marrow Transplantation;Aug2008 Supplement, Vol. 42, pS103 

    Malaysia conducted the first BMT in the country in 1987. Since then, there have been 1155 transplantations performed in a total of eight transplant centres. A majority of the transplantations were allogeneic, including myeloablative and nonmyeloablative. A vast majority of donors are HLA...

  • Blood and marrow transplantation in the People's Republic of China. Wu, T.; Lu, D. P. // Bone Marrow Transplantation;Aug2008 Supplement, Vol. 42, pS73 

    Syngeneic BMT was first performed successfully in China in 1964. In 1981, allogeneic BMT was applied in an acute leukemia patient with success. Since then, the number of BMTs has been increasing gradually, especially since the 1990s. More than 2000 stem cell transplants per year have been...

  • HLA matching affects clinical outcome of adult patients undergoing haematopoietic SCT from unrelated donors: a study from the Gruppo Italiano Trapianto di Midollo Osseo and Italian Bone Marrow Donor Registry. Crocchiolo, R.; Ciceri, F.; Fleischhauer, K.; Oneto, R.; Bruno, B.; Pollichieni, S.; Sacchi, N.; Sormani, M. P.; Fanin, R.; Bandini, G.; Bonifazi, F.; Bosi, A.; Rambaldi, A.; Alessandrino, P. E.; Falda, M.; Bacigalupo, A. // Bone Marrow Transplantation;Nov2009, Vol. 44 Issue 9, p571 

    The importance of HLA donor–recipient matching in unrelated haematopoietic SCT (HSCT) is the subject of debate. In this retrospective study, we analyzed 805 adult patients from the Italian Registry receiving HSCT for a haematological malignancy from January 1999 to June 2006 and...

  • Family donor care management: principles and recommendations. van Walraven, S. M.; Nicoloso-de Faveri, G.; Axdorph-Nygell, U. A. I.; Douglas, K. W.; Jones, D. A.; Lee, S. J.; Pulsipher, M.; Ritchie, L.; Halter, J.; Shaw, B. E. // Bone Marrow Transplantation;Aug2010, Vol. 45 Issue 8, p1269 

    The World Marrow Donor Association (WMDA) is an international organization fostering collaboration in clinical transplantation and promoting the interests of unrelated stem cell donors. The WMDA has developed standards for the recruitment, counseling, work-up and subsequent donations to protect...

  • Biliary complications after a right-lobe living donor liver transplantation. Yazumi, Shujiro; Chiba, Tsutomu // Journal of Gastroenterology;Sep2005, Vol. 40 Issue 9, p861 

    Right-lobe living donor liver transplantation (RL-LDLT) has become an acceptable procedure for adult patients with end-stage liver disease in this decade. However, biliary complications in RL-LDLT remain a serious problem: the incidence of anastomotic biliary leakage and stricture after RL-LDLT...

  • Quadrennial Review on Liver Transplantation. Ringe, Burckhardt // American Journal of Gastroenterology;Aug1994 Supplement, Vol. 89 Issue 8, pS18 

    Within the last years, liver transplantation has definitely come of age, and evolved to the standard treatment of choice for patients with endstage liver disease, and after ineffective conventional therapy. This development became possible on the basis of intensive interdisciplinary scientific...

  • Biliary complications in living liver donors. YUFENG YUAN; GOTOH, MITSUKAZU // Surgery Today;May2010, Vol. 40 Issue 5, p411 

    With the increasing use of living donor liver transplantation (LDLT), the morbidity and mortality of the donors have thus become inevitable problems associated with this procedure. The most common postoperative complications among donors for LDLT involve the biliary tract. The incidence of...

  • Acute biliary obstruction due to a large intracholedochal hematoma after living-donor liver transplantation: Report of a case. NAGATA, SHIGEYUKI; IKEGAMI, TORU; TAKEISHI, KAZUKI; TOSHIMA, TAKEO; SUGIMACHI, KEISHI; GION, TOMONOBU; SOEJIMA, YUJI; TAKETOMI, AKINOBU; MAEHARA, YOSHIHIKO // Surgery Today;May2010, Vol. 40 Issue 5, p474 

    This report presents a rare case of an acute biliary obstruction caused by the postoperative development of an intracholedochal hematoma in a 57-year-old female patient who underwent living-donor liver transplantation for end-stage liver disease of cryptogenic origin. This is the first report to...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics